Premedication With Nebulized Ketamine,Dexmedetomidine Versus Midazolam in Oncologic Preschool Children

Brief Summary

Evaluate the efficacy of nebulized dexmedetomidine, nebulized ketamine, and nebulized midazolam a premedication prior to general anesthesia (GA) in oncologic preschool children undergo bone marrow aspirate and biopsy.

Intervention / Treatment

  • Drug: nebulized ketamine
  • Drug: nebulized Dexmedetomidine
  • Drug: nebulized midazolam

Condition or Disease

  • Oncological Children

Phase

Study Design

Study type: Interventional
Status: Completed
Study results: No Results Available
Age: 3 Years to 7 Years   (Child)
Enrollment: 90 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Oct 16, 2020
Primary Completion: Sep 17, 2020
Completion Date: Oct 17, 2020
Study First Posted: Oct 18, 2016
Results First Posted: Aug 31, 2020
Last Updated: Jan 12, 2018

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Location

The preoperative period can be a traumatic time for young children undergoing surgery. Pediatric anesthesiologists strive to minimize distress for children in the operating room (OR) environment and to provide a smooth induction of anesthesia. Preoperative anxiety stimulates the sympathetic, parasympathetic, and endocrine systems, leading to an increase in heart rate (HR), blood pressure, and cardiac excitability. Various drugs have been advocated as premedication to allay anxiety and facilitate the smooth separation of children from parents. The ideal premedicant in children should be readily acceptable and should have a rapid and reliable onset with minimal side effects. Dexmedetomidine is a tasteless, colorless, and odorless drug that acts as a selective α-2 adrenergic agonist with both sedative and analgesic effects via actions in the central nervous system. Ketamine is an N-methyl-d-aspartate receptor antagonist that produces a state of sedation, anesthesia, immobility, analgesia, amnesia, and dissociation from the environment. Midazolam is a water-soluble benzodiazepine known to have a rapid onset and short duration of action, as well as properties of amnesia and anxiolysis. Administered intranasally, midazolam is an effective option for conscious sedation.

Eligibility Criteria

Sex: All
Minimum Age: 3
Maximum Age: 7

More Details

NCT Number: NCT02935959
Other IDs: 349
Study URL: https://ClinicalTrials.gov/show/NCT02935959
Last updated: Mar 18, 2021